What is Interson?
Interson Corporation operates at the intersection of medical device manufacturing and digital health, specializing in the development of USB-based ultrasound probes. By engineering hardware that integrates seamlessly with Windows-based platforms, the company has effectively democratized access to high-quality diagnostic imaging for both human medical practitioners and veterinary professionals. Their product portfolio is characterized by portability and affordability, addressing critical gaps in clinical diagnostic workflows. Beyond its proprietary product line, Interson maintains a robust OEM partnership program, providing customized transducer solutions that cater to niche medical applications and specialized diagnostic requirements.
How much funding has Interson raised?
Interson has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Interson
PPP
Public-Private Partnership
What's next for Interson?
Following this late-stage capital injection, Interson is well-positioned to accelerate its market penetration and enhance its research and development capabilities. The strategic allocation of these funds will likely focus on expanding the company's OEM footprint and refining its ultrasound imaging software to maintain a competitive edge in an increasingly digitized healthcare landscape. As the demand for portable, point-of-care diagnostic tools continues to rise globally, Interson's commitment to high-quality, accessible imaging technology provides a clear pathway for sustained growth and operational scaling in the coming fiscal periods.
See full Interson company page
